Skip to main content

Neuropsychological Testing in HIV-Infected Individuals

  • Living reference work entry
  • First Online:
Encyclopedia of AIDS

Definition

Recent estimates from the US Centers for Disease Control and Prevention were that 1.2 million individuals were living with HIV/AIDS in the United States and over 35 million worldwide (CDC 2013). The last few decades have witnessed dramatic improvements in the treatment and management of HIV disease, including the advent of combination antiretroviral therapy (cART) in 1996. These advances remarkably improved HIV-related health outcomes and transformed HIV from what was once a condition with very poor prognosis and high mortality rates into a more chronic, long-term manageable condition. Despite these significant advances, HIV-associated neuropsychological disorders (HAND), particularly in milder forms, remain highly prevalent in the cART era and can have significant adverse effects on everyday functioning and health-related outcomes.

This chapter will provide an overview of neurocognitive (NC) assessment as it pertains to the diagnosis of HAND in clinical and research...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • American Academy of Neurology AIDS Task Force. Criteria for diagnosis of HIV-1 associated dementia complex: nomenclature and research case definitions for neurologic manifestations of HIV-1 infection. Neurology. 1991;41:778–84.

    Article  Google Scholar 

  • Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Andrade AS, Deutsch R, Celano S, Duarte NA, Marcotte TD, Umlauf A, Atkinson JH, McCutchan JA, Franklin D, Alexander TJ, McArthur J. Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons. J Acquir Immune Defic Syndr. 2013;62:282–292.

    Google Scholar 

  • Becker JT, Dew MA, Aizenstein HJ, Lopez OL, Morrow L, Saxton J. Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease. AIDS Patient Care STDs. 2011;25:351–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Ellis RJ, Atkinson JH, Grant I, Heaton RK. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012;26:894–908.

    Article  CAS  PubMed  Google Scholar 

  • Blackstone K, Weber E, Iudicello JE, Woods SP. Real-world impact of HIV-associated neurocognitive impairment. In: Chiaravalloti N, Goverover T, editors. Changing brain, changes in daily life. New York: Springer; 2017.

    Google Scholar 

  • Butters N, Grant I, Haxby J, Judd LL, Martin A, McClelland J, Pequegnat W, Schacter D, Stover E. Assessment of AIDS-related cognitive changes: recommendations of the NIMH workshop on neuropsychological assessment approaches. J Clin Exp Neuropsychol. 1990;12:963–78.

    Article  CAS  PubMed  Google Scholar 

  • Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK, HNRC Group. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004a;26:307–19.

    Article  PubMed  Google Scholar 

  • Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, Marcotte TD, Grant I, Heaton RK, HNRC Group. Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol. 2004b;18:234–48.

    Article  PubMed  Google Scholar 

  • Casaletto KB, Umlauf A, Beaumont J, Gershon R, Slotkin J, Akshoomoff N, Heaton RK. Demographically corrected normative standards for the English version of the NIH toolbox cognition battery. J Int Neuropsychol Soc. 2015;21:378–91.

    Article  PubMed  PubMed Central  Google Scholar 

  • Centers for Disease Control and Prevention. HIV surveillance report, 2013, vol. 25. http://www.cdc.gov/hiv/library/reports/surveillance/. Published Feb 2015.

  • Cysique LA, Letendre SL, Ake C, Jin H, Franklin DR, Gupta S, Shi C, Yu X, Wu Z, Abramson IS, Grant I, Heaton RK, HNRC Group. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS. 2010;24:983–90.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cysique LA, Franklin Jr D, Abramson I, Ellis RJ, Letendre S, Collier A, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Grant I, Heaton RK, CHARTER Group, HNRC Group. Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol. 2011;33:505–22.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, Wolfson T, Marcotte T, Cherner M, Rippeth J, Grant I, HNRC Group. Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J Int Neuropsychol Soc. 2003;9:64–71.

    Article  PubMed  Google Scholar 

  • Grant I, Atkinson JH. Psychiatric aspects of acquired immune deficiency syndrome. In: Kaplan HI, Sadock BJ, editors. Comprehensive textbook of psychiatry, vol. 2. Baltimore: Williams and Wilkins; 1995. p. 1644–69.

    Google Scholar 

  • Grant I, Sacktor N. HIV-associated neurocognitive disorders. In: Gendelman HE, Grant I, Everall IP, Fox HS, Gelbard HA, Lipton SA, Swinells S, editors. The neurology of AIDS. 3rd ed. New York: Oxford University Press; 2011. p. 488–503.

    Chapter  Google Scholar 

  • Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD, Spector SA, McCutchan JA. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med. 1987;107:828–36.

    Article  CAS  PubMed  Google Scholar 

  • Heaton RK, Marcotte TD. Clinical and neuropsychological tests and assessment techniques. In: Boller F, Grafman J, Rizzolatti G, editors. Handbook of neuropsychology. Amsterdam: Elsevier Science; 2000. p. 27–52.

    Google Scholar 

  • Heaton RK, Kirson D, Velin RA, Grant I, HNRC Group. The utility of clinical ratings for detecting cognitive change in HIV infection. In: Grant I, Martin A, editors. Neuropsychology of HIV infection. New York: Oxford University Press; 1994. p. 188–206.

    Google Scholar 

  • Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, Wolfson T, Velin R, Marcotte TD, Hesselink JR, Jernigan TL, Chandler J, Wallace M, Abramson I, HNRC Group. The HNRC 500-neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc. 1995;1:231–51.

    Article  CAS  PubMed  Google Scholar 

  • Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources; 2004.

    Google Scholar 

  • Heaton RK, Clifford DB, Franklin Jr DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology. 2010;75:2087–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group, HNRC Group. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3–16.

    Article  CAS  PubMed  Google Scholar 

  • Heaton RK, Franklin Jr DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I, CHARTER Group. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015;60:473–80.

    Article  CAS  PubMed  Google Scholar 

  • Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Wolfson T, Letendre SL, Ellis RJ, Heaton RK, Gamst AC, Franklin Jr DR, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, CHARTER Group. Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol. 2011;17:248–57.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kamminga J, Cysique LA, Lu G, Batchelor J, Brew BJ. Validity of cognitive screens for HIV-associated neurocognitive disorder: a systematic review and an informed screen selection guide. Curr HIV/AIDS Rep. 2013;10:342–55.

    Article  PubMed  PubMed Central  Google Scholar 

  • Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I, HNRC Group. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS. 2006;20:879–87.

    Article  PubMed  Google Scholar 

  • Moore DJ, Roediger MJ, Eberly LE, Blackstone K, Hale B, Weintrob A, Ganesan A, Agan BK, Letendre SL, Crum-Cianflone NF. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort. PLoS One. 2012;7(11):e47310.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Navia B, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol. 1987;44:65–9.

    Article  CAS  PubMed  Google Scholar 

  • Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E. The international HIV dementia scale: a new rapid screening test for HIV dementia. AIDS. 2005;19:1367–74.

    PubMed  Google Scholar 

  • Scott JC, Woods SP, Vigil O, Heaton RK, Schweinsburg BC, Ellis RJ, Grant I, Marcotte TD. A neuropsychological investigation of multitasking in HIV infection: Implications for everyday functioning. Neuropsychology. 2011;25:511–519.

    Google Scholar 

  • Taylor MJ, Heaton RK. Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment. J Int Neuropsychol Soc. 2001;7:867–74.

    Article  CAS  PubMed  Google Scholar 

  • Temkin NR, Heaton RK, Grant I, Dikmen SS. Detecting significant change in neuropsychological test performance: a comparison of four models. J Int Neuropsychol Soc. 1999;5:357–69.

    Article  CAS  PubMed  Google Scholar 

  • Valcour V, Paul R, Chiao S, Wendelken LA, Miller B. Screening for cognitive impairment in human immunodeficiency virus. Clin Infect Dis. 2011;53:836–42.

    Article  PubMed  PubMed Central  Google Scholar 

  • Weintraub S, Dikmen SS, Heaton RK, Tulsky DS, Zelazo PD, Bauer PJ, Carlozzi NE, Slotkin J, Blitz D, Wallner-Allen K, Fox NA, Beaumont JL, Mungas D, Nowinski CJ, Richler J, Deocampo JA, Anderson JE, Manly JJ, Borosh B, Havlik R, Conway K, Edwards E, Freund L, King JW, Moy C, Witt E, Gershon RC. Cognition assessment using the NIH toolbox. Neurology. 2013;80:S54–64.

    Article  PubMed  PubMed Central  Google Scholar 

  • White DA, Heaton RK, Monsch AU, HNRC Group. Neuropsychological studies of asymptomatic human immunodeficiency virus-type 1 infected individuals. J Int Neuropsychol Soc. 1995;1:304–15.

    Article  CAS  PubMed  Google Scholar 

  • Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26:759–78.

    Article  PubMed  Google Scholar 

  • Woods SP, Childers M, Ellis RJ, Guaman S, Grant I, Heaton RK, HNRC Group. A battery approach for measuring neuropsychological change. Arch Clin Neuropsychol. 2006;21:83–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert K. Heaton .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media LLC

About this entry

Cite this entry

Heaton, R.K., Iudicello, J.E. (2016). Neuropsychological Testing in HIV-Infected Individuals. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_222-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9610-6_222-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-9610-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics